Nokian Renkaat Oyj (NRE1)
Vienna Exchange · Austria · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 13.47 |
|---|---|
| 52-week range | 8.02 – 16.60 |
| Return, 1 month / 3 months | −16.5% / −12.2% |
| Return, 1 year / 3 years | +70.3% / +108.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 28 |
| Volatility (1 year) | 38.6% |
| Worst drawdown (1 year) | -21.8% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | 1.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nokian Renkaat Oyj is a Finnish tyre manufacturer based in Nokia, Finland. It develops and makes tyres for cars and light trucks, with a strong emphasis on products for cold and demanding conditions, and it also produces heavy tyres for forestry, agricultural and industrial machinery. Its tyres are sold to motorists, fleets and professional users through tyre retailers and its own retail outlets in Nordic and other markets.
Nokian Renkaat Oyj trades under the code NRE1 on the Vienna Exchange in Austria, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nokian Renkaat Oyj (NRE1) trades on the Vienna Exchange in Austria. It last closed at EUR 13.47 on 22 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 44 of 84 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 70.3% and over the last three months it fell 12.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Vienna Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.5% | ||
| From 52-week high | -18.9% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | -12.2% | ||
| 6-month return | 40.3% | ||
| 12-month return, skipping the last month | 104.1% | ||
| Stability (higher is calmer) | 45 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 38.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.8% | ||
| Liquidity | 1 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 100.0% | ||
| Income | 61 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.9% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −4.1% |
|---|---|
| 1 month | −16.5% |
| 3 months | −12.2% |
| 6 months | +40.3% |
| 1 year | +70.3% |
| 3 years | +108.5% |
| 5 years | −41.0% |
Signals
| 50-day / 200-day average | 15.44 / 12.30 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.30 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 Mar 2026 | EUR 0.2500 |
| 8 May 2025 | EUR 0.2500 |
| 30 Oct 2024 | EUR 0.2000 |
| 30 Apr 2024 | EUR 0.3500 |
| 1 Nov 2023 | EUR 0.2000 |
| 27 Apr 2023 | EUR 0.3500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Vienna Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.